# Sea Cliff Partners Management, LP

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 2011655. Source: https://holderbook.com/funds/2011655-sea-cliff-partners-management-lp/

- Reported value: $225.5M
- Positions: 14
- Weight of the ten largest: 87.3%
- Filed: 2026-08-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SVCS INC | [BTSG](https://holderbook.com/stocks/BTSG/) | $38.3M | 548,934 | 17.0% | 8 |
| LIFE TIME GROUP HOLDINGS INC | [LTH](https://holderbook.com/stocks/LTH/) | $25.8M | 631,900 | 11.4% | 3 |
| WESCO INTL INC | [WCC](https://holderbook.com/stocks/WCC/) | $24.9M | 72,000 | 11.0% | 4 |
| OKTA INC | [OKTA](https://holderbook.com/stocks/OKTA/) | $21.8M | 160,000 | 9.7% | 8 |
| JAMES HARDIE INDS PLC | [JHX](https://holderbook.com/stocks/JHX/) | $16.8M | 640,270 | 7.4% | 4 |
| INTEGER HLDGS CORP | [ITGR](https://holderbook.com/stocks/ITGR/) | $16.6M | 177,113 | 7.3% | 3 |
| ONEMAIN HLDGS INC | [OMF](https://holderbook.com/stocks/OMF/) | $14.8M | 242,991 | 6.6% | 2 |
| SURGERY PARTNERS INC | [SGRY](https://holderbook.com/stocks/SGRY/) | $14.2M | 845,864 | 6.3% | 3 |
| HEXCEL CORP NEW | [HXL](https://holderbook.com/stocks/HXL/) | $12.1M | 120,605 | 5.4% | 10 |
| JBT MAREL CORPORATION | [JBTM](https://holderbook.com/stocks/JBTM/) | $11.7M | 80,600 | 5.2% | 1 |
| COURSERA INC | [COUR](https://holderbook.com/stocks/COUR/) | $9.5M | 1,681,200 | 4.2% | 1 |
| ARXIS INC | [ARXS](https://holderbook.com/stocks/ARXS/) | $9.0M | 195,000 | 4.0% | 1 |
| GODADDY INC | [GDDY](https://holderbook.com/stocks/GDDY/) | $6.4M | 75,000 | 2.8% | 11 |
| TOAST INC | [TOST](https://holderbook.com/stocks/TOST/) | $3.8M | 136,264 | 1.7% | 1 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +34.5% | +14.8% | +19.7% | 93% |
| Q1 2026 | -5.9% | -4.6% | -1.2% | 100% |
| Q4 2025 | +2.3% | +2.4% | -0.1% | 100% |
| Q3 2025 | -2.5% | +7.8% | -10.4% | 100% |
| Q2 2025 | +10.1% | +10.5% | -0.3% | 100% |
| Q1 2025 | -6.5% | -4.6% | -1.9% | 100% |
| Q4 2024 | -1.9% | +2.1% | -4.1% | 100% |
| Q3 2024 | -0.4% | +5.4% | -5.8% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $225.5M | 14 |
| Q1 2026 | $193.7M | 13 |
| Q4 2025 | $237.3M | 13 |
| Q3 2025 | $261.4M | 15 |
| Q2 2025 | $293.3M | 15 |
| Q1 2025 | $278.4M | 15 |
| Q4 2024 | $288.3M | 15 |
| Q3 2024 | $298.3M | 15 |
| Q2 2024 | $292.2M | 14 |
| Q1 2024 | $304.4M | 15 |
| Q4 2023 | $256.5M | 14 |